Life Science Investing Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis
Life Science Investing Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis and Systemic Lupus Erythematosus
Life Science Investing Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Life Science Investing Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
Life Science Investing Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference
Life Science Investing Adicet Bio Announces First Systemic Sclerosis Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
life science investing Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference
life science investing Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
life science investing Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
life science investing Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy 28th Annual Meeting
life science investing Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference
Providence Gold Mines Inc. Receives Regulatory Approvals for Fundamental Transaction & The La Dama de Oro Gold Property NI 43-101 Report
CHARBONE Announces the Reception of the Main Components at the Sorel-Tracy Site and the Launch of Civil Works
CHARBONE annonce la reception des principales composantes sur le site de Sorel-Tracy et le lancement des travaux civils
